References
- Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2016. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 14:150–156.
- Akbarzadeh A, Samiei M, Davaran S. 2012. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7:144.
- Anari E, Akbarzadeh A, Zarghami N. 2015. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1029633.
- Banerjee SS, Aher N, Patil R, Khandare J. 2012. Poly(ethylene glycol)-prodrug conjugates: concept, design, and applications. J Drug Deliv. 2012:103973.
- Gilje S, Han S, Wang M, Wang KL, Kaner BR. 2007. A chemical route to graphene for device applications. Nano Lett. 7:3394–3398.
- Hu W, Peng C, Luo W, Lv M, Li X, Li D, Huang Q, Fan C. 2010. Graphene-based antibacterial paper. ACS Nano. 4:4317–4323.
- Kuila T, Bose S, Mishra A, Khara P, Kim NH, Lee JH. 2012. Chemical functionalization of graphene and its applications. Prog Mater Sci. 57:1061–1105.
- Liu J, Cui L, Losic D. 2013. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 9:9243–9257.
- Liu T, Wang C, Gu X, Gong H, Cheng L, Shi X, et al. 2014. Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater Weinheim. 26:3433–3440.
- Liu Z, Robinson JT, Sun X, Dai H. 2008. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 130:10876–10877.
- Mirakabad FST, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, Badrzadeh F, Rahmati-Yamchi M. 2016. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44:423–430.
- Moldeus P, Högberg J, Orrenius S. 1978. Isolation and use of liver cells. Methods Enzymol. 52:60–71.
- Mossman T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
- Ni Y, Zhang F, Kokot S. 2013. Graphene oxide as a nanocarrier for loading and delivery of medicinal drugs and as a biosensor for detection of serum albumin. Analytica Chimica Acta. 769:40–48.
- Poh HL, Šanek F, Ambrosi A, Zhao G, Sofer Z, Pumera M. 2012. Graphenes prepared by Staudenmaier, Hofmann and Hummers methods with consequent thermal exfoliation exhibit very different electrochemical properties. Nanoscale. 4:3515–3522.
- Rana VK, Choi MC, Kong JY, Kim GY, Kim MJ, Kim SH, et al. 2011. Synthesis and drug-delivery behavior of chitosan-functionalized graphene oxide hybrid nanosheets. Macromol Mater Eng. 296:131–140.
- Seabra AB, Paula AJ, de Lima R, Alves OL, Durán N. 2014. Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol. 27:159–168.
- Shahriary L, Athawale AA. 2014. Graphene oxide synthesized by using Modified Hummers approach. Renew Energy Environ Eng. 02:58–63.
- Sharma H, Kumar K, Choudhary C, Mishra PK, Vaidya B. 2016. Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug. Artif Cells Nanomed Biotechnol. 44:672–679.
- Singh D, Singh S, Sahu J, Srivastava S, Singh MR. 2016. Ceramic nanoparticles: recompense, cellular uptake and toxicity concerns. Artif Cells Nanomed Biotechnol. 44:401–409.
- Veronese FM, Pasut G. 2005. PEGylation, successful approach to drug delivery. Drug Discov Today. 10:1451–1458.
- Wang K, Ruan J, Song H, Zhang J, Wo Y, Guo S, Cui D. 2011. Biocompatibility of graphene oxide. Nanoscale Res Lett. 6:1–8.
- Xianbo M, Zeeshan A, Song L, Nongyue JH. 2015. Applications of magnetic nanoparticles in targeted drug delivery system. J Nanosci Nanotechnol. 15:54–62.
- Zhu Y, Liao L. 2015. Applications of nanoparticles for anticancer drug delivery: a review. J Nanosci Nanotechnol. 15:4753–4773.